This project will focus on novel interactions between breast cancer cells and tumor associated macrophages that contribute to increased tumor malignancy. Our previous studies have defined an EGFR/CSF1R paracrine loop operating between these two cell types and its role in invasion and intravasation. In this proposal we will evaluate additional novel interactions between tumor cells and macrophages which could be critical for patient survival. We propose that neuregulins and CXCR2 ligands secreted by tumor cells activate ErbB3 and CXCR2 on macrophages, resulting in increased production of AREG, HBEGF and angiogenic factors by macrophages. HBEGF and AREG simulate tumor cell invasiveness, while the angiogenic factors disrupt the endothelial barrier, with the combined results leading to increased intravasafion. We propose three specific aims in which we will test these hypotheses.
In Aim 1 we will evaluate the role of stimulation of macrophage ErbB3 by neuregulins secreted by tumor cells.
In Aim 2 we will evaluate the role of macrophage CXCR2.
In Aim 3, we will examine the roles of HBEGF, AREG and angiogenic factors produced by macrophages. The project will integrate the use of in vitro and in vivo models of intravasation and extravasation provided by Cores A, B, and C to study the role of these pathways in breast cancer metastasis. Close collaboration with the other projects in the PPG will facilitate evaluation of macrophage polarizafion and dynamics during invasion and metastasis (Project 1), mechanisms of CSFl R synergy with ErbBS and GPCR signaling (Projects 2 and 4), and the roles played by the ErbB3/CXCR2 pathways contributing to the various steps in transendothelial migration (Project 5). The ultimate goal is to identify new options for prognosis and therapeutic interventions.
Breast cancer is the second highest cause of death due to cancer in women, demonstrating the need to develop new methods for treating it. This project will test the roles of specific signaling interactions between tumor cells and macrophages with the long term goal of improving prognosis and treatment.
|Khalil, Bassem D; Hanna, Samer; Saykali, Bechara A et al. (2014) The regulation of RhoA at focal adhesions by StarD13 is important for astrocytoma cell motility. Exp Cell Res 321:109-22|
|Noy, Roy; Pollard, Jeffrey W (2014) Tumor-associated macrophages: from mechanisms to therapy. Immunity 41:49-61|
|Roh-Johnson, M; Bravo-Cordero, J J; Patsialou, A et al. (2014) Macrophage contact induces RhoA GTPase signaling to trigger tumor cell intravasation. Oncogene 33:4203-12|
|Bergman, Aviv; Condeelis, John S; Gligorijevic, Bojana (2014) Invadopodia in context. Cell Adh Migr 8:273-9|
|Zhou, Z N; Sharma, V P; Beaty, B T et al. (2014) Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo. Oncogene 33:3784-93|
|Weitsman, Gregory; Lawler, Katherine; Kelleher, Muireann T et al. (2014) Imaging tumour heterogeneity of the consequences of a PKC?-substrate interaction in breast cancer patients. Biochem Soc Trans 42:1498-505|
|Gligorijevic, Bojana; Bergman, Aviv; Condeelis, John (2014) Multiparametric classification links tumor microenvironments with tumor cell phenotype. PLoS Biol 12:e1001995|
|Hanna, Samer; Khalil, Bassem; Nasrallah, Anita et al. (2014) StarD13 is a tumor suppressor in breast cancer that regulates cell motility and invasion. Int J Oncol 44:1499-511|
|Stanley, E Richard; Chitu, Violeta (2014) CSF-1 receptor signaling in myeloid cells. Cold Spring Harb Perspect Biol 6:|
|Rohan, Thomas E; Xue, Xiaonan; Lin, Hung-Mo et al. (2014) Tumor microenvironment of metastasis and risk of distant metastasis of breast cancer. J Natl Cancer Inst 106:|
Showing the most recent 10 out of 127 publications